BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38477420)

  • 1. LRRK2 regulates ferroptosis through the system Xc-GSH-GPX4 pathway in the neuroinflammatory mechanism of Parkinson's disease.
    Zheng Z; Zhang S; Liu X; Wang X; Xue C; Wu X; Zhang X; Xu X; Liu Z; Yao L; Lu G
    J Cell Physiol; 2024 May; 239(5):e31250. PubMed ID: 38477420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nilotinib inhibits microglia-mediated neuroinflammation to protect against dopaminergic neuronal death in Parkinson's disease models.
    Wu J; Xu X; Zheng L; Mo J; Jin X; Bao Y
    Int Immunopharmacol; 2021 Oct; 99():108025. PubMed ID: 34364303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease.
    Yao L; Zhu Z; Wu J; Zhang Y; Zhang H; Sun X; Qian C; Wang B; Xie L; Zhang S; Lu G
    FASEB J; 2019 Jul; 33(7):8648-8665. PubMed ID: 30995872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson's disease.
    Yao L; Ye Y; Mao H; Lu F; He X; Lu G; Zhang S
    J Neuroinflammation; 2018 Jan; 15(1):13. PubMed ID: 29329581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson's Disease Mice and LPS-Induced BV2 Cells.
    Huang P; Zhang Z; Zhang P; Feng J; Xie J; Zheng Y; Liang X; Zhu B; Chen Z; Feng S; Wang L; Lu J; Liu Y; Zhang Y
    Mol Neurobiol; 2024 May; 61(5):2590-2605. PubMed ID: 37917301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EriB targeted inhibition of microglia activity attenuates MPP
    Dou F; Chu X; Zhang B; Liang L; Lu G; Ding J; Chen S
    Mol Brain; 2018 Dec; 11(1):75. PubMed ID: 30563578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RND3 modulates microglial polarization and alleviates neuroinflammation in Parkinson's disease by suppressing NLRP3 inflammasome activation.
    Hu W; Wang M; Sun G; Zhang L; Lu H
    Exp Cell Res; 2024 Jun; 439(1):114088. PubMed ID: 38744409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease.
    Kim BW; Koppula S; Kumar H; Park JY; Kim IW; More SV; Kim IS; Han SD; Kim SK; Yoon SH; Choi DK
    Neuropharmacology; 2015 Oct; 97():46-57. PubMed ID: 25983275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early glycolytic reprogramming controls microglial inflammatory activation.
    Cheng J; Zhang R; Xu Z; Ke Y; Sun R; Yang H; Zhang X; Zhen X; Zheng LT
    J Neuroinflammation; 2021 Jun; 18(1):129. PubMed ID: 34107997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-survival and anti-inflammatory roles of NF-κB c-Rel in the Parkinson's disease models.
    Wang Z; Dong H; Wang J; Huang Y; Zhang X; Tang Y; Li Q; Liu Z; Ma Y; Tong J; Huang L; Fei J; Yu M; Wang J; Huang F
    Redox Biol; 2020 Feb; 30():101427. PubMed ID: 31986466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome.
    Kou L; Chi X; Sun Y; Han C; Wan F; Hu J; Yin S; Wu J; Li Y; Zhou Q; Zou W; Xiong N; Huang J; Xia Y; Wang T
    J Neuroinflammation; 2022 Jun; 19(1):133. PubMed ID: 35668454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson's disease models.
    Liu Z; Shen C; Li H; Tong J; Wu Y; Ma Y; Wang J; Wang Z; Li Q; Zhang X; Dong H; Yang Y; Yu M; Wang J; Zhou R; Fei J; Huang F
    J Neuroinflammation; 2023 Apr; 20(1):96. PubMed ID: 37072793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Non-coding RNA HOTAIR Promotes Parkinson's Disease Induced by MPTP Through up-regulating the Expression of LRRK2.
    Liu S; Cui B; Dai ZX; Shi PK; Wang ZH; Guo YY
    Curr Neurovasc Res; 2016; 13(2):115-20. PubMed ID: 26979073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson's Disease Mouse Models.
    Park JE; Leem YH; Park JS; Kim DY; Kang JL; Kim HS
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leucine-rich repeat kinase-2 (LRRK2) modulates microglial phenotype and dopaminergic neurodegeneration.
    Dwyer Z; Rudyk C; Thompson A; Farmer K; Fenner B; Fortin T; Derksen A; Sun H; Hayley S;
    Neurobiol Aging; 2020 Jul; 91():45-55. PubMed ID: 32247534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wuzi Yanzong Pill relieves MPTP-induced motor dysfunction and neuron loss by inhibiting NLRP3 inflammasome-mediated neuroinflammation.
    Pan T; Xiao Q; Fan HJ; Xu L; Qin SC; Yang LX; Jin XM; Xiao BG; Zhang B; Ma CG; Chai Z
    Metab Brain Dis; 2023 Oct; 38(7):2211-2222. PubMed ID: 37470879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fyn Kinase Regulates Microglial Neuroinflammatory Responses in Cell Culture and Animal Models of Parkinson's Disease.
    Panicker N; Saminathan H; Jin H; Neal M; Harischandra DS; Gordon R; Kanthasamy K; Lawana V; Sarkar S; Luo J; Anantharam V; Kanthasamy AG; Kanthasamy A
    J Neurosci; 2015 Jul; 35(27):10058-77. PubMed ID: 26157004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-218-5p-Ddx41 axis restrains microglia-mediated neuroinflammation through downregulating type I interferon response in a mouse model of Parkinson's disease.
    Wang D; Gao H; Qin Q; Li J; Zhao J; Qu Y; Li J; Xiong Y; Min Z; Mao Z; Xue Z
    J Transl Med; 2024 Jan; 22(1):63. PubMed ID: 38229084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erinacine A Prevents Lipopolysaccharide-Mediated Glial Cell Activation to Protect Dopaminergic Neurons against Inflammatory Factor-Induced Cell Death In Vitro and In Vivo.
    Lee SL; Hsu JY; Chen TC; Huang CC; Wu TY; Chin TY
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.